Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis-Reference-Cited by-同舟云学术

Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis

Published:2023-10 Issue: Volume:957 Page:175989
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Buyl Karolien^ORCID,Vrints Martine,Fernando Ruani,Desmae Terry,Van Eeckhoutte Thomas,Jans Mia,Van Der Schueren Jan,Boeckmans Joost,Rodrigues Robim M.,De Boe Veerle,Rogiers Vera,De Kock Joery,Beirinckx Filip,Vanhaecke Tamara

Funder

Agentschap Innoveren en Ondernemen

Galápagos

Publisher

Elsevier BV

Subject

Pharmacology

Reference87 articles.

1. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD);Ahmed;Drug Discov. Today,2007

2. Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism;Aljohani;Trends Endocrinol. Metabol.,2017

3. Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial;Alkhouri;J. Hepatol.,2022

4. GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH);Alkhouri;Expet Opin. Invest. Drugs,2020

5. De novo lipogenesis in health and disease;Ameer;Metabolism,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation;Cell Reports Medicine;2024-03